Efficacy and safety of lucitanib plus nivolumab in patients with advanced gynecologic malignancies: Phase 2 results from the LIO-1 study (NCT04042116; ENGOT-GYN3/AGO/LIO) Meeting Abstract
| Authors: | Patel, M. R.; Makker, V.; Oaknin, A.; Pignata, S.; Backes, F. J.; Martin, A. G.; Eskander, R. N.; Pothuri, B.; Richardson, D. L.; Secord, A. A.; Van Nieuwenhuysen, E.; Liu, J. F.; Musa, F.; Penson, R. T.; Wride, K.; Lepley, D. M.; Dusek, R.; Cameron, T.; Hamilton, E. P.; Concin, N. |
| Abstract Title: | Efficacy and safety of lucitanib plus nivolumab in patients with advanced gynecologic malignancies: Phase 2 results from the LIO-1 study (NCT04042116; ENGOT-GYN3/AGO/LIO) |
| Meeting Title: | 2022 ASCO Annual Meeting |
| Journal Title: | Journal of Clinical Oncology |
| Volume: | 40 |
| Issue: | 16 Suppl. |
| Meeting Dates: | 2022 Jun 3-7 |
| Meeting Location: | Chicago, IL |
| ISSN: | 0732-183X |
| Publisher: | American Society of Clinical Oncology |
| Date Published: | 2022-06-01 |
| Language: | English |
| ACCESSION: | WOS:000863680301570 |
| PROVIDER: | wos |
| DOI: | 10.1200/JCO.2022.40.16_suppl.5517 |
| Notes: | Meeting Abstract: 5517 -- Meeting also held virtually -- Source: Wos |
